Legislation and Regulation in the U.S.

US Regulatory Comments

As part of its advocacy program in the US, ACRO submits regulatory comments to US regulators – such as the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).  ACRO’s US regulatory comments are listed below in reverse chronological order, organized by Agency.

ACRO US Regulatory Comments

2018 Comments

FDA

2017 Comments

FDA

2016 Comments

FDA

2015 Comments

FDA

NIH

OHRP

2014 Comments

FDA